The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Neoadjuvant chemotherapy (NACT) could affect the levels of squamous cell carcinoma antigen (SCC-Ag). This study evaluates the predictive value of pre- and posttreatment SCC-Ag levels in patients with cervical cancer who were treated with NACT followed by radical surgery.A total of 286 patients with...
Main Authors: | Xiong Li, Jin Zhou, Kecheng Huang, Fangxu Tang, Hang Zhou, Shaoshuai Wang, Yao Jia, Haiying Sun, Ding Ma, Shuang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4393273?pdf=render |
Similar Items
-
Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery.
by: Jin Zhou, et al.
Published: (2016-01-01) -
Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? A large-scale retrospective study.
by: Ting Hu, et al.
Published: (2015-01-01) -
The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy
by: Miao‐Fang Wu, et al.
Published: (2019-09-01) -
A case of neoadjuvant chemotherapy in pregnancy with cervical cancer (IB3)
by: Xiaohua Li, et al.
Published: (2024-01-01) -
Survival outcomes and risk factors of patients with stage ⅡB cervical cancer undergoing neoadjuvant chemotherapy followed by radical hysterectomy
by: ZHOU Dan, et al.
Published: (2023-06-01)